Micah Grey: Shaping the Future of Hematology at ISTH 2026
Micah Grey, US Medical, Rare Blood Disorders Fellow US Medical, Rare Blood Disorders Fellow at Sanofi, shared a post on LinkedIn:
“This week, I attended the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, France. It was an incredible week of learning, engaging in scientific discussions, and connecting with healthcare professionals and researchers from around the world.
Beyond the congress, it was a privilege to experience and be immersed in the rich French culture, making the week even more memorable.
Major shoutout to my team, for their continued mentorship and support, I am truly appreciative of each and every one of them.
It’s exciting to witness the continued innovation shaping the future of hematology, and I’m grateful to grow in the rare blood disorders space.
Looking forward to continuing to learn, contribute, and embrace the opportunities ahead.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight